SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-044849
Filing Date
2023-06-01
Accepted
2023-06-01 13:27:17
Documents
15
Period of Report
2023-06-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea179639-8k_inmedpha.htm   iXBRL 8-K 40319
2 NEWS RELEASE, DATED JUNE 1, 2023 ea179639ex99-1_inmedpha.htm EX-99.1 12851
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3394
  Complete submission text file 0001213900-23-044849.txt   278024

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20230601.xsd EX-101.SCH 3202
5 XBRL DEFINITION FILE inm-20230601_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20230601_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20230601_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea179639-8k_inmedpha_htm.xml XML 4331
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 23983981
SIC: 2834 Pharmaceutical Preparations